Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7716
+0.0136 (1.79%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Rein Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Current | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 72 | 52 | 46 | 29 | 32 | 39 | 50 | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Market Cap Growth (YoY) | 129.82% | 34.41% | -7.39% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Enterprise Value | 71.74 | 52.83 | 42.93 | 24.86 | 26.54 | 31.52 | 36.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Last Close Price | 0.77 | 1.30 | 1.16 | 1.15 | 1.40 | 1.77 | 2.30 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Debt / Equity Ratio | 0.42 | 0.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 |
Net Debt / EBITDA Ratio | -0.01 | -0.01 | 0.06 | 0.07 | 0.09 | 0.12 | 0.20 | 0.60 | 0.86 | 0.66 | 1.07 | 0.89 | 0.76 | 0.70 | 0.77 | 0.86 | 1.08 | 1.36 | 1.73 | 2.18 |
Net Debt / FCF Ratio | -0.03 | -0.03 | 0.17 | 0.19 | 0.27 | 0.32 | 0.58 | 0.63 | 0.85 | 0.59 | 0.87 | 0.88 | 0.72 | 0.77 | 0.85 | 0.95 | 1.20 | 1.51 | 1.92 | 2.33 |
Quick Ratio | 0.33 | 0.33 | 0.52 | 0.70 | 0.74 | 1.24 | 2.24 | 3.12 | 4.44 | 2.66 | 3.95 | 7.45 | 11.44 | 5.81 | 6.28 | 5.62 | 6.29 | 9.19 | 10.19 | 11.46 |
Current Ratio | 0.40 | 0.40 | 0.70 | 0.90 | 0.86 | 1.39 | 2.38 | 3.30 | 4.69 | 2.82 | 4.17 | 7.88 | 11.66 | 5.93 | 6.46 | 5.96 | 6.51 | 9.65 | 10.69 | 11.93 |
Return on Equity (ROE) | -352.23% | -352.23% | -139.87% | -117.09% | -115.52% | -117.52% | -82.37% | -30.22% | -25.31% | -19.05% | -26.91% | -86.78% | -111.28% | -144.00% | -87.41% | -88.83% | -82.50% | -69.02% | -93.33% | -78.24% |
Return on Assets (ROA) | -199.23% | -199.23% | -115.62% | -104.87% | -102.53% | -106.02% | -75.57% | -28.17% | -23.69% | -18.00% | -25.43% | -78.61% | -101.05% | -123.77% | -78.44% | -78.61% | -73.12% | -63.19% | -82.09% | -67.45% |
Return on Invested Capital (ROIC) | -389.97% | -389.97% | -178.78% | -143.95% | -144.79% | -151.27% | -106.74% | -37.80% | -32.23% | -23.05% | -40.63% | - | - | - | - | - | - | - | - | - |
Return on Capital Employed (ROCE) | -328.13% | -328.13% | -136.07% | -116.41% | -115.50% | -117.52% | -82.39% | -29.58% | -24.76% | -18.82% | -27.07% | -91.81% | -115.78% | -147.35% | -88.33% | -89.28% | -82.84% | -70.02% | -94.42% | -76.63% |
Buyback Yield / Dilution | -29.11% | -29.33% | -41.84% | -72.30% | -138.40% | -284.48% | -290.09% | -200.85% | -106.59% | -21.97% | -1.31% | -0.10% | -0.18% | -0.28% | -2.23% | -18.82% | -42.66% | -85.81% | -154.70% | -142.03% |
Total Shareholder Return | -29.11% | -29.33% | -41.84% | -72.30% | -138.40% | -284.48% | -290.09% | -200.85% | -106.59% | -21.97% | -1.31% | -0.10% | -0.18% | -0.28% | -2.23% | -18.82% | -42.66% | -85.81% | -154.70% | -142.03% |